The New Jersey-based drugmaker expects 2025 sales of between $90.9 billion and $91.7 billion, and to earn between $10.75 and ...
Quarterly sales of J&J's cancer drugs rose 19% worldwide, driven by more than $3 billion for multiple myeloma treatment ...
Kenvue, the worlds largest pure-play consumer health company by revenue and the makers of ORSL® electrolyte drinks, today ...